ArticleJTO clinical and research reports2022

The Role of Chemotherapy Plus Immune Checkpoint Inhibitors in Oncogenic-Driven NSCLC: A University of California Lung Cancer Consortium Retrospective Study.

David J Benjamin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.